The higher circulating IA was associated with increased MAGE in T2DM patients (23), thus greater GV may be due to greater IA levels in the premixed insulin group potentially, which indicate that those patients with elevated IA levels should receive GV assessment and individualized treatment. The gene discussed is INS; the disease is type 2 diabetes mellitus.